At the request of Clinical Laserthermia Systems AB, Clinical Laserthermia
Systems AB equity rights will be traded on First North as from June 1, 2021.
Security name: Clinical Laserthermia Systems AB TO 3 B
-------------------------------------------------------
Short name: CLS TO 3 B
-------------------------------------------------------
ISIN code: SE0015812243
-------------------------------------------------------
Orderbook ID: 226688
-------------------------------------------------------
Terms: Issue price, 70% of VWAP during the ten trading days immediately
before April 6 2022, per share.
Maximum issue price 5,25 SEK per share and minimum issue price
3,5 SEK per B-share.
1 option right gives the right to subscribe for 1 new B-share in
Clinical Laserthermia Systems AB.
--------------------------------------------------------------------------------
Subscription April 11, 2022 - April 25, 2022
period:
--------------------------------------------------------------------------------
Last trading April 21, 2022
date:
--------------------------------------------------------------------------------
Security name: Clinical Laserthermia Systems AB TO 4 B
-------------------------------------------------------
Short name: CLS TO 4 B
-------------------------------------------------------
ISIN code: SE0015812250
-------------------------------------------------------
Orderbook ID: 226689
-------------------------------------------------------
Terms: Issue price, 70% of VWAP during the ten trading days immediately
before April 6 2023, per share.
Maximum issue price 7 SEK per share and minimum issue price 4,2
SEK per share.
1 option right gives the right to subscribe for 1 new B-share in
Clinical Laserthermia Systems AB.
--------------------------------------------------------------------------------
Subscription April 11, 2023 - April 25, 2023
period:
--------------------------------------------------------------------------------
Last trading April 21, 2023
date:
--------------------------------------------------------------------------------
This information is distributed at the request of the Certified Adviser, FNCA
Sweden AB. For further information, please call FNCA Sweden ABon +46 8 528 00
399.© 2021 GlobeNewswire
